Efficacy of Seventh Generation Bonding Agents as Short-Term Desensitizers Among Patients With Hypersensitivity
NCT04225247
·
clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
105
Enrollment
OTHER
Sponsor class
Conditions
Dentin Hypersensitivity
Interventions
DRUG:
Single Bond Universal
DRUG:
Bifluorid 12
DRUG:
Xeno V+
Sponsor
Dow University of Health Sciences